ADVERTISEMENT by Gilead — Taking Steps Towards a Future Free from HIV
ADVERTISEMENT by Gilead — Taking Steps Towards a Future Free from HIV
4 months ago
nytimes.com
Gilead s $7.8B Arcellx Acquisition: A Real-World Case Study | DeciBio posted on the topic | LinkedIn
Gilead s $7.8B Arcellx Acquisition: A Real-World Case Study | DeciBio posted on the topic | LinkedIn
2 views1 month ago
linkedin.com
Gilead : Phase 2b Study Of Sacituzumab Govitecan On Aggressive Type Of Breast Cancer Meets Main Goal
Gilead : Phase 2b Study Of Sacituzumab Govitecan On Aggressive Type Of Breast Cancer Meets Main Goal
Nov 10, 2021
nasdaq.com
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Aug 18, 2020
marketscreener.com
Gilead Sciences: Global Health and Access
Gilead Sciences: Global Health and Access
Sep 17, 2024
gilead.com
Gilead believes WHO post had inappropriate characterization of study
2:55
Gilead believes WHO post had inappropriate characterization of study
Apr 23, 2020
CNBCMeg Tirrell
At Gilead, we're focused on delivering transformative therapies in #HIV and pushing the boundaries of scientific innovation in our mission to help end the epidemic. Here's what it takes. | Gilead Sciences
0:56
At Gilead, we're focused on delivering transformative therapies in #HIV and pushing the boundaries of scientific innovation in our mission to help end the epidemic. Here's what it takes. | Gilead Sciences
89.9K views9 months ago
FacebookGilead Sciences
0:23
When it comes to #HIV prevention and care, trusted community spaces can open doors that clinics sometimes can't. Through a Gilead HIV-supported initiative, barbers turned everyday haircuts into powerful discussions about sexual health – helping young people see these conversations as essential, not taboo. Learn more: https://gilead.inc/44c5DCu | Gilead Sciences
53K views10 months ago
FacebookGilead Sciences
1:05
At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife | Gilead Sciences
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:16
Our Building 324 is no ordinary research building. It’s a space built through the collaboration of scientists, architects, engineers and employees – and it has just received a 2021 Facility of the Year Award from the International Society for Pharmaceutical Engineering. See how we’re building collaborative, environmentally sustainable and operationally agile workspaces that inspire innovation: https://bit.ly/3eGJ5PA | Gilead Sciences
43.1K viewsApr 27, 2021
FacebookGilead Sciences
0:21
At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we’re driving change and working toward our vision to create a healthier world for all people. https://gilead.inc/3Eu4JHC #GileadLife | Gilead Sciences
25.6K views11 months ago
FacebookGilead Sciences
2:21
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. In this installment of The Centrifuge Sessions, See Phan, Vice President, Oncology Clinical Development, discusses Gilead’s approach to cancer research and how his team is working to deliver innovative therapies that offer new hope for patients. | Gilead Sciences
31.1K viewsApr 10, 2025
FacebookGilead Sciences
0:28
These are Gilead scientists. They’re not just experts in oncology, virology and inflammation: They’re relentless thinkers with an unwavering commitment to discovery. Here, in our labs, every intricate step, reset and do-over plays a critical role in helping set and achieve bold ambitions in our fight against the world’s most devastating diseases. #GileadLife | Gilead Sciences
93.8K views8 months ago
FacebookGilead Sciences
0:09
At Gilead, we work in close partnership with organizations that share our ambitions. For the past 15 years we’ve collaborated with Emory University on AIDSVu, an online mapping tool that helps communities better understand what #HIV looks like across the United States. Watch to learn how this tool can help us get closer to our goal of ending the epidemic. https://gilead.inc/3GgOTjS | Gilead Sciences
276 viewsApr 9, 2025
FacebookGilead Sciences
2:38
Gilead Sciences earnings top estimates, boosts full-year outlook
10.1K views8 months ago
YahooYahoo Finance Video
0:58
At Gilead, we’ve spent decades focusing on #HIV and pushing the boundaries of scientific innovation. The story of HIV prevention is one of persistence, progress and possibility – and we won’t stop until we reach our ultimate goal of ending the epidemic. | Gilead Sciences
77.8K views11 months ago
FacebookGilead Sciences
0:25
Time takes on a new meaning for people living with cancer. Brian Weist reaffirms the importance of working with urgency to accelerate innovative treatments. At Gilead and Kite, A Gilead Company, we’re guided by a shared commitment to address the greatest gaps in care. | Gilead Sciences
58.7K views4 months ago
FacebookGilead Sciences
0:47
“Every minute, every hour, every day that we work brings a medicine closer and closer to being available for patients.” A new video series showcases the accomplished, imaginative and dedicated individuals who have committed their careers to helping drive innovation and improve human health. In the first installment, Gilead’s Daejin Abidoye and Oriana Wiklund discuss their shared goal of advancing cancer treatments and shed light on what it’s like working here. https://bit.ly/3Er0cQo | Gilead Sci
571 viewsOct 28, 2021
FacebookGilead Sciences
0:52
Join us at the 31st Conference of the Asian Pacific Association for the Study of the Liver, where we’ll present four new abstracts as part of our ongoing commitment to liver research. At Gilead, we’ve been at the forefront of advancing the care of people living with liver disease, including viral hepatitis. Through collaboration, we can help achieve the 2030 hepatitis elimination goal and create a healthier world. #APASL2022 | Gilead Sciences
73.8K viewsMar 28, 2022
FacebookGilead Sciences
1:16
Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19
Jun 1, 2020
CNBCMeg Tirrell
1:35
Gilead Sciences helped transform hepatitis C treatment and developed breakthrough treatments in HIV - and they’re just getting started. They’re committed to tackling today’s toughest health challenges, from HIV to cancer, while fueling local economies and creating cutting-edge research jobs. Their $32B investment in manufacturing and R&D facilities in the U.S. will power the next generation of treatments for patients while supporting local economies and skilled workers. Hear more from CEO Daniel
82 views3 months ago
FacebookPhRMA
Gilead Sciences Reports Positive Data From Phase 3 ASCENT-04/KEYNOTE-D19 Study
Jan 26, 2008
finanznachrichten.de
0:26
#PrimaryBiliaryCholangitis (PBC) is a rare, chronic autoimmune disease that damages the liver’s bile ducts. We’re committed to advancing transformative care for people with PBC. | Gilead Sciences
893K viewsJul 26, 2024
FacebookGilead Sciences
0:43
For more than 35 years, Gilead has been at the forefront of tackling some of the world’s greatest public health challenges. We’re committed to delivering innovative therapies and working to improve the lives of patients around the world. #GileadLife | Gilead Sciences
74.5K views11 months ago
FacebookGilead Sciences
Two thirds of Covid-19 patients improve after Gilead drug: Study
Apr 11, 2020
India TodayReuters
1:06
COVID-19 patients respond to Gilead drug: report
Apr 17, 2020
YahooReuters Videos
What does Gilead mean in the Bible? - TimesMojo
Jul 7, 2022
timesmojo.com
Gilead Sciences (NasdaqGS:GILD) Gains FDA Approval For Yeztugo As PrEP HIV Option
10 months ago
YahooSimply Wall St
3:11
Gilead Sciences posts mixed Q1 results
11 months ago
Yahoo
0:45
Hear from Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, as he explains why addressing #HIV treatment resistance, which cannot be reversed once it occurs, is critical to our efforts to help end the epidemic. | Gilead Sciences
721.7K viewsFeb 29, 2024
FacebookGilead Sciences
See more